Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Abbott Laboratories (0Q15)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
110.1124 -1.2776    -1.15%
11:32:13 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United Kingdom
ISIN:  US0028241000 
SEDOL:  BYMPY19
  • Volume: 37,369
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 110.0683 - 110.8686
Abbott Labs 110.1124 -1.2776 -1.15%

0Q15 Income Statement

 
Featured here, the Income Statement (earnings report) for Abbott Laboratories, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 10241 10143 9978 9747
Revenue 10241 10143 9978 9747
Other Revenue, Total - - - -
Cost of Revenue, Total 4531 4605 4483 4314
Gross Profit 5710 5538 5495 5433
Total Operating Expenses 8184 8374 8315 8069
Selling/General/Admin. Expenses, Total 2578 2601 2619 2615
Research & Development 594 672 715 649
Depreciation / Amortization 332 328 302 315
Interest Expense (Income) - Net Operating -70 -166 -159 -153
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 308 334 355 329
Operating Income 2057 1769 1663 1678
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets -39 - - -
Other, Net 301 98 27 116
Net Income Before Taxes 1795 1671 1636 1562
Provision for Income Taxes 201 235 261 244
Net Income After Taxes 1594 1436 1375 1318
Minority Interest 224 213 230 222
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1594 1436 1375 1318
Total Extraordinary Items - - - -
Net Income 1594 1436 1375 1318
Total Adjustments to Net Income -6 -5 -5 -6
Income Available to Common Excluding Extraordinary Items 1588 1431 1370 1312
Dilution Adjustment 4.93 2.4 9.81 4.19
Diluted Net Income 1589.07 1433.6 1365.19 1313.81
Diluted Weighted Average Shares 1748 1748.29 1750.25 1751.72
Diluted EPS Excluding Extraordinary Items 0.908 0.82 0.78 0.75
DPS - Common Stock Primary Issue 0.55 0.51 0.51 0.51
Diluted Normalized EPS 0.665 0.597 0.584 0.575
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
James Cooley
James Cooley Mar 15, 2024 3:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what baby formula is all these companies being sued for?
Suraj Tschand
Suraj Tschand Mar 14, 2024 4:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ABT is a success story. There FreeStyle for diabetes is the best seller. The unit tells a diabetic person what foods cause the glucose spikes. The stock shot up because of their runaway successful Covid rapid tester. It has gone up by 20% this year and before we know it, it will be hitting $150.
Mauro Mariotti
Mauro Mariotti Sep 27, 2023 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Caspita sotto 100....
Michael Gad
Michael Gad Feb 10, 2023 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy 108.3
Jonah Garber
Jonah Garber Aug 08, 2022 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals
wayne lim
wayne lim Aug 07, 2022 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
super boom
wayne lim
wayne lim Aug 07, 2022 9:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
super boom
sean delaney
sean delaney Sep 09, 2021 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Boom!!
John Cerniuk
John Cerniuk Jul 21, 2021 6:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its coiled like a snake it's ready to spring
Mahdi Hatami
Mahdi Hatami Jun 15, 2021 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best time to buy ABT!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email